Abstract
Objective
Adjustable differential pressure (DP) valves in combination with fixed anti-siphon devices are currently a popular combination in counteracting the effects of cerebrospinal fluid overdrainage following implantation of a ventriculoperitoneal shunt system. The study examined the flow performance of three DP valves in successive combination with an anti-siphon device in an in vitro shunt laboratory with and without vertical motion.
Methods
We analyzed three DP valves (Codman Hakim Medos programmable valve [HM], Codman CertasPlus [CP], and Miethke proGAV [PG], in combination with either Codman SiphonGuard [SG] or Miethke ShuntAssistant [SA]), resulting in the evaluation of six different valve combinations. Defined DP conditions between 4 and 40 cm H2O within a simulated shunt system were generated and the specific flow characteristics were measured. In addition, combinations with SA, which is a gravity-dependent valve, were measured in defined spatial positions (90°, 60°). All device combinations were tested during vertical motion with movement frequencies of 2, 3, and 4 Hz.
Results
All valve combinations effectively counteracted the siphon effect in relation to the chosen DP. Angulation-related flow changes were similar in the three combinations of DP valve and SA in the 60° and 90° position. In CP-SA and PG-SA, repeated vertical movement at 2, 3, and 4 Hz led to significant increase in flow, whereas in HM-SA, constant increase was seen at 4 Hz only (flow change at 4Hz, DP 40 cm H2O: PG (opening pressure 4 cm H2O) 90°: 0.95 ml/min, 60°: 0.71 ml/min; HM (opening pressure 4 cm H2O) 90°: 0.66 ml/min, 60°: 0.41 ml/min; CP (PL 2) 90°: 0.94 ml/min, 60°: 0.79 ml/min; p < 0.01); however, HM-SA showed relevant motion-induced flow already at low DPs (0.85 ml/min, DP 4 cm H2O). In combinations of DP valve with SG, increase of flow was far less pronounced and even led to significant reduction of flow in certain constellations. Maximum overall flow increase was 0.46 ± 0.04 ml/min with a HM (opening pressure 12 cm H2O) at 2 Hz and a DP of 10 cm H2O, whereas maximum flow decrease was 1.12 ± 0.08 with a PG (opening pressure 4 cm H2O) at 3 Hz and a DP of 10 cmH2O.
Conclusion
In an experimental setup, all valve combinations effectively counteracted the siphon effect in the vertical position according to their added resistance. Motion-induced increased flow was consistently demonstrated in combinations of DP valve and SA. The combination of HM and SA especially showed relevant motion-induced flow already at low DPs. In combinations of DP and SG, the pattern of the motion induced flow was more inconsistent and motion even led to significant flow reduction, predominantly at DPs of 10 and 20 cmH2O.
Similar content being viewed by others
References
CERTASTM Plus Programmable Valves, Hydrocephalus Catalog, Codman Specialty Surgical https://www.integralife.com/file/general/1549983654.pdf. Last accessed 15 Apr 2020
Chong CCW, van Gelder J, Sheridan M (2002) Clinical experience with the low pressure Novus valve in the treatment of adult hydrocephalus. J Clin Neurosci 9(5):539–543
Czosnyka Z, Czosnyka M, Pickard JD (1999) Hydrodynamic performance of a new siphon preventing device: the SiphonGuard. JNNP 66(3):408–409
Czosnyka Z, Czosnyka M, Richards HK, Pickard JD (2002) Laboratory testing of hydrocephalus shunts – conclusion of the U.K. Shunt evaluation programme. Acta Neurochir (Wien) 144(6):525–538 discussion 538
Czosnyka Z, Pickard D, Czosnyka M (2013) Hydrodynamic properties of the Certas hydrocephalus shunt - laboraty investigation. J Neurosurg Pediatr 11:198–204
Davis C, Lauritzen CG (2008) Spring-assisted remodeling for ventricular shunt-induced cranial deformity. J Craniofacial Surg 19:588–592
Davis SE, Levy ML, McComb JG, Sposto R (2000) The delta valve: how does its clinical performance compare with two other pressure differential valves without antisiphon control? Pediatr Neurosurg 33(2):58–63
Fox JL, McCullough DC, Green RC (1973) Effect ofcerebrospinal fluid shunts on intracranial pressure and on cerebrospinal fluid dynamics. 2. A new technique of pressure measurements: results and concepts. 3. A concept of hydrocephalus. J Neurol Neurosurg Psychiatry 36:302–312
Freimann FB, Kimura T, Stockhammer F, Schulz M, Rohde V, Thomale UW (2014) In vitro performance and principles of anti- siphoning devices. Acta Neurochir 156:2191–2199
Freimann FB, Luhdo ML, Rohde V, Vajkoczy P, Wolf S, Sprung C (2014) The Frankfurt horizontal plane as a reference for the implantation of gravitational units: a series of 376 adult patients. Acta Neurochir (Wien). https://doi.org/10.1007/s00701-014-2076-y
Freimann FB, Vajkoczy P, Sprung C (2013) Patients benefit from low-pressure settings enabled by gravitational valves in normal pressure hydrocephalus. Clin Neurol Neurosurg. https://doi.org/10.1016/j.clineuro.2013.06.010
Gebert AF, Schulz M, Haberl H, Thomale U-W (2013) Adjustments in gravitational valves for the treatment of childhood hydrocephalus- a retrospective survey. Childs Nerv Syst. https://doi.org/10.1007/s00381-013-2160-2
Gruber RW, Roehrig B (2010) Prevention of ventricular catheter obstruction and slit ventricle syndrome by the prophylactic use of the Integra antisiphon device in shunt therapy for pediatric hypertensive hydrocephalus: a 25-year follow-up study. J Neurosurg Pediatr 5(1):4–16
Kestle JRW, Walker ML, Investigators S (2005) A multicenter prospective cohort study of the Strata valve for the management of hydrocephalus in pediatric patients. J Neurosurg 102(2 Suppl):141–145
Kiefer M, Eymann R, Meier U (2002) Five years experience with gravitational shunts in chronic hydrocephalus of adults. Acta Neurochir (Wien) 144(8):755–767 discussion 767
Kimura T, Schulz M, Shimoji K, Miyajima M, Arai H, Thomale UW (2016) In vitro performance of the fixed and adjustable gravity-assisted unit with and without motion - evidence of motion-induced flow. Acta Neurochir 158:2011–2018
Kurtom KH, Magram G (2007) Siphon regulatory devices: their role in the treatment of hydrocephalus. Neurosurg Focus 22(4):E5
Lemcke J, Meier U, Müller C, Fritsch MJ, Kehler U, Langer N, Kiefer M, Eymann R, Schuhmann MU, Speil A, Weber F, Remenez V, Rohde V, Ludwig HC, Stengel D (2013) Safety and efficacy of gravitational shunt valves in patients with idiopathic normal pressure hydrocephalus: a pragmatic, randomised, open label, multicentre trial (SVASONA). J Neurol Neurosurg Psychiatry 84(8):850–857
Major O, Fedorcsák I, Sipos L, Hantos P, Kónya E, Dobronyi I, Paraicz E (1994) Slit-ventricle syndrome in shunt operated children. Acta Neurochir (Wien) 127(1–2):69–72
Rainer JH (1988) Vibrations in structures induced by man and machine. Can J Civ Eng 15(6):1086–1987
Rekate HL (2004) The slit ventricle syndrome: advances based on technology and understanding. Pediatr Neurosurg 40:259–263
Rohde V, Haberl E-J, Ludwig H, Thomale U-W (2009) First experiences with an adjustable gravitational valve in childhood hydrocephalus. J Neurosurg Pediatr 3(2):90–93
Serlo W, Heikkinen E, Saukkonen AL, von Wendt L (1985) Classification and management of the slit ventricle syndrome. Childs Nerv Syst 1:194–199
Toma AK, Tarnaris A, Kitchen ND, Watkins LD (2011) Use of proGAV® shunt valve in normal pressure hydrocephalus. Neurosurgery. https://doi.org/10.1227/NEU.0b013e318214a809
Weinzweig J, Bartlett SP, Chen JC, Losee J, Sutton L, Duhaime AC, Whitaker LA (2008) Cranial vault expansion in the management of post-shunt craniosynostosis and slit ventricle syndrome. Plast Reconstr Surg 122:1171–1180
Funding
No funding was received for this research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
UWT is consultant for Miethke Company and receives lecture honorarium from B. Braun-Aesculap Company. Author IF declares that he has no conflict of interest. Author PR declares that she has no conflict of interest. Author CVDB declares that he has no conflict of interest. Author CB declares that he has no conflict of interest. Author NH declares that he has no conflict of interest. Author FF declares that he has no conflict of interest. Author VR declares that he has no conflict of interest. Author SB declares that he has no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on CSF Circulation
Electronic supplementary material
ESM 1
(DOCX 918 kb)
Rights and permissions
About this article
Cite this article
Fiss, I., Röhrig, P., Hore, N. et al. In vitro performance of six combinations of adjustable differential pressure valves and fixed anti-siphon devices with and without vertical motion. Acta Neurochir 162, 2421–2430 (2020). https://doi.org/10.1007/s00701-020-04519-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-020-04519-y